Logo image of ALKOM.PA

PLASTICOS COMPUESTOS SA (ALKOM.PA) Stock Fundamental Analysis

EPA:ALKOM - Euronext Paris - Matif - ES0105425005 - Common Stock - Currency: EUR

1.01  0 (0%)

Fundamental Rating

2

Overall ALKOM gets a fundamental rating of 2 out of 10. We evaluated ALKOM against 0 industry peers in the Unkown industry. ALKOM may be in some trouble as it scores bad on both profitability and health. ALKOM has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALKOM has reported negative net income.
ALKOM had a positive operating cash flow in the past year.
ALKOM had negative earnings in each of the past 5 years.
In the past 5 years ALKOM always reported a positive cash flow from operatings.
ALKOM.PA Yearly Net Income VS EBIT VS OCF VS FCFALKOM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

Industry RankSector Rank
ROA -0.49%
ROE -1.21%
ROIC 4.34%
ROA(3y)-1.45%
ROA(5y)-1.83%
ROE(3y)-4.01%
ROE(5y)-4.99%
ROIC(3y)N/A
ROIC(5y)N/A
ALKOM.PA Yearly ROA, ROE, ROICALKOM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

ALKOM's Operating Margin has declined in the last couple of years.
ALKOM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.8%
PM (TTM) N/A
GM 17.28%
OM growth 3Y43.28%
OM growth 5Y-1.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y2.56%
ALKOM.PA Yearly Profit, Operating, Gross MarginsALKOM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALKOM is destroying value.
Compared to 1 year ago, ALKOM has more shares outstanding
ALKOM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ALKOM has been reduced compared to a year ago.
ALKOM.PA Yearly Shares OutstandingALKOM.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALKOM.PA Yearly Total Debt VS Total AssetsALKOM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

ALKOM has an Altman-Z score of 1.67. This is a bad value and indicates that ALKOM is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of ALKOM is 7.12, which is on the high side as it means it would take ALKOM, 7.12 years of fcf income to pay off all of its debts.
ALKOM has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 7.12
Altman-Z 1.67
ROIC/WACC0.4
WACC10.8%
ALKOM.PA Yearly LT Debt VS Equity VS FCFALKOM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.86 indicates that ALKOM may have some problems paying its short term obligations.
ALKOM has a Quick Ratio of 0.86. This is a bad value and indicates that ALKOM is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.27
ALKOM.PA Yearly Current Assets VS Current LiabilitesALKOM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ALKOM have decreased strongly by -33.00% in the last year.
Looking at the last year, ALKOM shows a decrease in Revenue. The Revenue has decreased by -4.71% in the last year.
ALKOM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.98% yearly.
EPS 1Y (TTM)-33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.04%
Revenue 1Y (TTM)-4.71%
Revenue growth 3Y-9.25%
Revenue growth 5Y-0.98%
Sales Q2Q%3.27%

3.2 Future

The Earnings Per Share is expected to grow by 144.95% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALKOM will show a small growth in Revenue. The Revenue will grow by 6.94% on average per year.
EPS Next Y233.33%
EPS Next 2Y144.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.93%
Revenue Next 2Y6.94%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALKOM.PA Yearly Revenue VS EstimatesALKOM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
ALKOM.PA Yearly EPS VS EstimatesALKOM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2022 2023 2024 2025 2026 0 0.05 0.1 0.15 0.2 0.25

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALKOM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 6.67, the valuation of ALKOM can be described as very cheap.
ALKOM is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.67
ALKOM.PA Price Earnings VS Forward Price EarningsALKOM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF 11.5
EV/EBITDA 4.61
ALKOM.PA Per share dataALKOM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALKOM's earnings are expected to grow with 144.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y144.95%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALKOM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLASTICOS COMPUESTOS SA

EPA:ALKOM (5/8/2025, 7:00:00 PM)

1.01

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.28M
Analysts84
Price Target1.98 (96.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.8%
PT rev (3m)-7.8%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)15.38%
EPS NY rev (3m)15.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.67
P/S 0.28
P/FCF 11.5
P/OCF 5.51
P/B 0.93
P/tB 1.18
EV/EBITDA 4.61
EPS(TTM)-0.01
EYN/A
EPS(NY)0.15
Fwd EY15%
FCF(TTM)0.09
FCFY8.7%
OCF(TTM)0.18
OCFY18.15%
SpS3.62
BVpS1.09
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.49%
ROE -1.21%
ROCE 5.9%
ROIC 4.34%
ROICexc 4.8%
ROICexgc 5.65%
OM 2.8%
PM (TTM) N/A
GM 17.28%
FCFM 2.43%
ROA(3y)-1.45%
ROA(5y)-1.83%
ROE(3y)-4.01%
ROE(5y)-4.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.08%
ROICexcg growth 5Y2.72%
ROICexc growth 3Y38.52%
ROICexc growth 5Y2.66%
OM growth 3Y43.28%
OM growth 5Y-1.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y2.56%
F-Score4
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 7.12
Debt/EBITDA 0.84
Cap/Depr 46.86%
Cap/Sales 2.64%
Interest Coverage 0.86
Cash Conversion 60.12%
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.27
Altman-Z 1.67
F-Score4
WACC10.8%
ROIC/WACC0.4
Cap/Depr(3y)31.27%
Cap/Depr(5y)45.34%
Cap/Sales(3y)1.84%
Cap/Sales(5y)2.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.04%
EPS Next Y233.33%
EPS Next 2Y144.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.71%
Revenue growth 3Y-9.25%
Revenue growth 5Y-0.98%
Sales Q2Q%3.27%
Revenue Next Year5.93%
Revenue Next 2Y6.94%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.28%
EBIT growth 3Y30.02%
EBIT growth 5Y-2.54%
EBIT Next Year173.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.81%
OCF growth 3Y56.63%
OCF growth 5Y-0.01%